Aarti Drugs offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antifungals, antibiotic, antidiabetic, sedative and vitamins. Its products under APIs include Aceclofenac, Diclofenac Potassium, Diclofenac Diethylamine, Clopidogrel Bisulphate and Telmisartan. The stock rose 360% during the last one year and climbed Rs 561 against the close of Rs 155.71. Its share trades higher than 5 day, 20 day and 200 day moving averages, but lower than 50 day and 100 day moving averages. The market cap of the firm stood at Rs 6,628 crore.